Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome?

被引:1
作者
Christodoulidis, Georgios [1 ]
Baber, Usman [1 ]
Mehran, Roxana [1 ,2 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Cardiovasc Res Fdn, New York, NY USA
关键词
acute coronary syndromes; dual antiplatelet therapy; percutaneous coronary intervention; DUAL-ANTIPLATELET THERAPY; DRUG-ELUTING STENT; MYOCARDIAL-INFARCTION; CLOPIDOGREL THERAPY; DOUBLE-BLIND; IMPLANTATION; THROMBOSIS; DISCONTINUATION; INTERVENTION; MANAGEMENT;
D O I
10.1097/HCO.0000000000000070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To provide updates regarding the optimal duration of dual antiplatelet therapy (DAPT) in patients with acute coronary syndromes (ACS). Recent findings Within the past years, five moderate-sized randomized controlled trials evaluated different DAPT durations after percutaneous coronary intervention. These studies included a significant percentage of ACS patients that varied from 30 to 75% depending on the study. Results suggest that in selected populations prolonging DAPT does not offer additional protection from ischemic events and increases bleeding complications. However, results from a large-scale registry illustrate that DAPT durations beyond 6 months are associated with lower cardiovascular risk. Moreover, a multicenter registry demonstrated that the context underlying DAPT cessation is an additional correlate of outcomes after stent implantation. Summary Current guidelines suggest 12 months of DAPT after an initial presentation with ACS. Emerging evidence suggest that in selected populations shorter duration might be acceptable.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 28 条
[1]   Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].
Airoldi, Flavio ;
Colombo, Antonio ;
Morici, Nuccia ;
Latib, Azeem ;
Cosgrave, John ;
Buellesfeld, Lutz ;
Bonizzoni, Erminio ;
Carlino, Mauro ;
Gerckens, Ulrich ;
Godino, Cosmo ;
Melzi, Gloria ;
Michev, Iassen ;
Montorfano, Matteo ;
Sangiorgi, Giuseppe Massimo ;
Qasim, Asif ;
Chieffo, Alaide ;
Briguori, Carlo ;
Grube, Eberhard .
CIRCULATION, 2007, 116 (07) :745-754
[2]  
[Anonymous], EUR HEART J
[3]   Medical Management After Coronary Stent Implantation A Review [J].
Brilakis, Emmanouil S. ;
Patel, Vishal G. ;
Banerjee, Subhash .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (02) :189-198
[4]   Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study [J].
Byrne, Robert A. ;
Schulz, Stefanie ;
Mehilli, Julinda ;
Ijima, Raisuke ;
Massberg, Steffen ;
Neumann, Franz-Josef ;
ten Berg, Jurrien M. ;
Schoemig, Albert ;
Kastrati, Adnan .
AMERICAN HEART JOURNAL, 2009, 157 (04) :620-624
[5]   Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials [J].
Cassese, Salvatore ;
Byrne, Robert A. ;
Tada, Tomohisa ;
King, Lamin A. ;
Kastrati, Adnan .
EUROPEAN HEART JOURNAL, 2012, 33 (24) :3078-+
[6]   Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].
Daemen, Joost ;
Wenaweser, Peter ;
Tsuchida, Keiichi ;
Abrecht, Linda ;
Sophia, Vaina ;
Morger, Cyrill ;
Kukreja, Neville ;
Jueni, Peter ;
Sianos, Georgios ;
Hellige, Gerrit ;
van Domburg, Ron T. ;
Hess, Otto M. ;
Boersma, Eric ;
Meier, Bernhard ;
Windecker, Stephan ;
Serruys, Patrick W. .
LANCET, 2007, 369 (9562) :667-678
[7]   Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation [J].
Eisenstein, Eric L. ;
Anstrom, Kevin J. ;
Kong, David F. ;
Shaw, Linda K. ;
Tuttle, Robert H. ;
Mark, Daniel B. ;
Kramer, Judith M. ;
Harrington, Robert A. ;
Matchar, David B. ;
Kandzari, David E. ;
Peterson, Eric D. ;
Schulman, Kevin A. ;
Califf, Robert M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02) :159-168
[8]   Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial [J].
Feres, Fausto ;
Costa, Ricardo A. ;
Abizaid, Alexandre ;
Leon, Martin B. ;
Marin-Neto, J. Antonio ;
Botelho, Roberto V. ;
King, Spencer B., III ;
Negoita, Manuela ;
Liu, Minglei ;
de Paula, J. Eduardo T. ;
Mangione, Jose A. ;
Meireles, George X. ;
Castello, Helio J., Jr. ;
Nicolela, Eduardo L., Jr. ;
Perin, Marco A. ;
Devito, Fernando S. ;
Labrunie, Andre ;
Salvadori, Decio, Jr. ;
Gusmao, Marcos ;
Staico, Rodolfo ;
Costa, J. Ribamar ;
de Castro, Juliana P. ;
Abizaid, Andrea S. ;
Bhatt, Deepak L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23) :2510-2522
[9]   Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study [J].
Gwon, Hyeon-Cheol ;
Hahn, Joo-Yong ;
Park, Kyung Woo ;
Bin Song, Young ;
Chae, In-Ho ;
Lim, Do-Sun ;
Han, Kyoo-Rok ;
Choi, Jin-Ho ;
Choi, Seung-Hyuk ;
Kang, Hyun-Jae ;
Koo, Bon-Kwon ;
Ahn, Taehoon ;
Yoon, Jung-Han ;
Jeong, Myung-Ho ;
Hong, Taek-Jong ;
Chung, Woo-Young ;
Choi, Young-Jin ;
Hur, Seung-Ho ;
Kwon, Hyuck-Moon ;
Jeon, Dong-Woon ;
Kim, Byung-Ok ;
Park, Si-Hoon ;
Lee, Nam-Ho ;
Jeon, Hui-Kyung ;
Jang, Yangsoo ;
Kim, Hyo-Soo .
CIRCULATION, 2012, 125 (03) :505-U119
[10]   ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J].
Hamm, Christian W. ;
Bassand, Jean-Pierre ;
Agewall, Stefan ;
Bax, Jeroen ;
Boersma, Eric ;
Bueno, Hector ;
Caso, Pio ;
Dudek, Dariusz ;
Gielen, Stephan ;
Huber, Kurt ;
Ohman, Magnus ;
Petrie, Mark C. ;
Sonntag, Frank ;
Uva, Miguel Sousa ;
Storey, Robert F. ;
Wijns, William ;
Zahger, Doron .
EUROPEAN HEART JOURNAL, 2011, 32 (23) :2999-3054